News

All eyes were on Dana Boucher, 67, after he received his first dose of LUTATHERA®, a targeted radiation treatment, to treat his neuroendocrine cancer.

“There must have been a dozen people outside my hospital room at any given time,” Dana says. “Since I was the first patient at Saint Luke’s to undergo LUTATHERA therapy, doctors, nurses, and hospital administrators were all interested to see how I was doing.”